Peginterferon Alfacon-2

Peginterferon alfacon-2 · Beijing Kawin Technology Share-Holding Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Peginterferon Alfacon-2, covering 2024-08-09 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection [Phase 3]